Invitation to presentation of Q4 2021 results

ArcticZymes Technologies presents its report for the fourth quarter and the full year 2021 on Thursday, 27 January 2022 at 08.30 a.m. The company will host an online presentation for investors, analysts, and media at 08:30 a.m. on Thursday, 27 January 2022, which will be followed by a Q&A session. CEO, Jethro Holter and CFO, Børge Sørvoll will hold the presentation. Participants who want to …

AZ ISO 13485:2016 recertification

ArcticZymes AS has been ISO 13485:2016 recertified!

ArcticZymes AS is delighted to achieve ISO 13485:2016 recertification. ISO 13485:2016 is an internationally recognized medical device standard that demonstrates excellence in Quality Management System´s (QMS) and best practice in product development, manufacturing, and supply of the products to meet the needs of customers and pertinent regulatory requirements. ArcticZymes AS continuously works to strengthen its QMS to ensure that all …

ArcticZymes Technologies launches new products and opens new production facility

ArcticZymes Technologies launches new products and opens new production facility ArcticZymes technologies launches the following products: ArcticZymes R2DTM Ligase – Patent pending ligase with novel specificity enabling the ligation of DNA to both ends of RNA using a DNA splint. The enzyme is an enabling tool for new technology development and is expected to have broad applicability in Molecular Diagnostics …